Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …

Answer questions and earn CME/CNE Patients with breast cancer commonly use
complementary and integrative therapies as supportive care during cancer treatment and to …

Importance Patient-reported outcome (PRO) data from clinical trials can provide valuable
evidence to inform shared decision making, labeling claims, clinical guidelines, and health …

Importance Accelerated approval (AA) is a US Food and Drug Administration (FDA)
expedited program intended to speed the approval of drugs and biologics that may …

Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on
the impact of disease and treatment on patients' symptoms, function and quality of life. High …

To date, there are no specific therapeutic strategies for treatment of COVID-19. Based on the
hypothesis that complement and coagulation cascades are activated by viral infection, and …

The clinical development of cancer therapeutics is a global undertaking, and incorporation
of the patient experience into the clinical decision-making process is of increasing interest to …

Population Comprehensive evaluation of chronic pain in older adults is multifaceted.
Objective and Methods Research on chronic pain in older adults needs to be guided by …

The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

With the advent of immunotherapeutic agents, durable and dramatic responses have been
observed in several hard-to-treat malignancies, outlining a roadmap to conquering cancer …